Insider Buying: Ansell Limited (ASX:ANN) Insider Purchases 426 Shares of Stock

Ansell Limited (ASX:ANN) insider Debra (Debbie) Goodin purchased 426 shares of the company’s stock in a transaction that occurred on Wednesday, February 26th. The stock was bought at an average price of A$35.10 ($21.80) per share, for a total transaction of A$14,952.17 ($9,287.06).

Debra (Debbie) Goodin also recently made the following trade(s):

• On Friday, February 21st, Debra (Debbie) Goodin bought 1,427 shares of Ansell stock. The shares were acquired at an average price of A$35.50 ($22.05) per share, for a total transaction of A$50,658.50 ($31,464.91).

Ansell Stock Performance

The company has a debt-to-equity ratio of 45.24, a current ratio of 3.84 and a quick ratio of 1.13. The stock has a market capitalization of $3.33 billion, a PE ratio of 39.82, a P/E/G ratio of -14.40 and a beta of 0.46.

Ansell Increases Dividend

The firm also recently announced a Interim dividend, which will be paid on Wednesday, March 5th. Shareholders of record on Wednesday, March 5th will be given a dividend of $0.353 per share. This is a boost from Ansell’s previous Interim dividend of $0.25. The ex-dividend date is Thursday, February 13th. This represents a yield of 0.95%. Ansell’s payout ratio is presently 67.06%.

About Ansell

Ansell Limited designs, develops, and manufactures protection solutions in the Asia Pacific, Europe, the Middle East, Africa, Latin America, the Caribbean, and North America. It operates in two segments, Healthcare and Industrial. The Healthcare segment manufactures and markets solutions comprising surgical gloves, single use and examination gloves, and clean and sterile gloves and garments, as well as consumables used by hospitals, surgical centers, dental practices, veterinary clinics, first responders, manufacturers, auto repair shops, chemical plants, laboratories, and life sciences and pharmaceutical companies.